Tiziana Life Sciences (TLSA) Receivables (2017 - 2022)
Tiziana Life Sciences (TLSA) posted quarterly Receivables of $4.8 million for Q4 2022, up 175.81% year-over-year from $1.8 million in Q4 2021, and up 175.81% quarter-over-quarter from $1.8 million in Q4 2021.
Tiziana Life Sciences (TLSA) Receivables (2017 - 2022) Analysis & Trends
Tiziana Life Sciences' Receivables history runs 6 years deep, the most recent figure standing at $4.8 million for Q4 2022.
- In Q4 2022, Receivables rose 175.81% year-over-year to $4.8 million; the TTM figure through Dec 2022 stood at $4.8 million (up 175.81% YoY), while the FY2022 annual figure was $4.8 million, up 175.81% from the prior year.
- Receivables for Q4 2022 stood at $4.8 million, up from $1.8 million in the prior quarter.
- The five-year high for Receivables was $4.8 million in Q4 2022, with the low at $72204.8 in Q2 2018.
- The 5-year median for Receivables is $897855.9 (2020), against an average of $1.5 million.
- The sharpest annual moves came in 2018 and 2020: Receivables plunged 92.81% in 2018, then surged 693.13% in 2020.
- Tiziana Life Sciences' Receivables stood at $319118.3 in 2018, then jumped by 92.59% to $614576.5 in 2019, then surged by 92.19% to $1.2 million in 2020, then soared by 48.76% to $1.8 million in 2021, then jumped by 175.81% to $4.8 million in 2022.
- Business Quant data shows TLSA's Receivables at $4.8 million in Q4 2022, $1.8 million in Q4 2021, and $1.2 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | - |
| 10 | Tiziana Life Sciences | 133.07 Mn | 129.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 4.85 Mn |
| Dec 31, 2021 | 1.76 Mn |
| Dec 31, 2020 | 1.18 Mn |
| Jun 30, 2020 | 2.50 Mn |
| Dec 31, 2019 | 614,576.50 |
| Jun 30, 2019 | 315,146.59 |
| Dec 31, 2018 | 319,118.27 |
| Jun 30, 2018 | 72,204.81 |
| Dec 31, 2017 | 4.44 Mn |